MEETINGS - Segmentation and Targeting in Medical Markets (UK) September 1998:
This article was originally published in Clinica
Executive Summary
A meeting entitled Segmentation and Targeting in Medical Markets will take place in London on September 7. An overview of medical market segmentation will be given and discussion will cover topics such as segmentation in the medical devices and in vitro diagnostics markets; assessment of potential and addressed market sizes; the influence of product and channel fit on market penetration; and the use of the internet for circulating information to the public. For more details contact the conference organiser, Henry Stewart Conference Studies, in the UK. Tel: +44 171 404 3040. Fax: +44 171 404 2081.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.